Clearwater Capital Advisors Portfolio holdings
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$24.5M |
| 2 |
iShares International Equity Factor ETF
INTF
|
+$14.2M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$10.5M |
| 4 |
First Trust Preferred Securities and Income ETF
FPE
|
+$6.21M |
| 5 |
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
|
+$5.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.67% |
| 2 | Healthcare | 0.34% |
| 3 | Consumer Discretionary | 0.33% |
| 4 | Communication Services | 0.12% |
| 5 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Seres Therapeutics
MCRB
$47.9M
| $79K | 0.01% |
618
| – | – |
|
|
NVTA
152
DELISTED
Invitae Corporation
NVTA
| $25K | ﹤0.01% |
10,234
| – | – |
|
153
Red Cat Holdings
RCAT
$1.32B
| $24K | ﹤0.01% |
14,500
| – | – |
|
154
GeneDx Holdings
WGS
$2.08B
| $14K | ﹤0.01% |
486
| – | – |
|
155
Compugen
CGEN
$218M
| $10K | ﹤0.01% |
14,976
| – | – |
|
156
Exelon
EXC
$46.7B
| – | – |
-5,180
| Closed | -$235K |
|
157
First Trust Health Care AlphaDEX Fund
FXH
$1.05B
| – | – |
-2,000
| Closed | -$206K |
|
158
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| – | – |
-4,431
| Closed | -$226K |
|
159
Pfizer
PFE
$149B
| – | – |
-4,269
| Closed | -$224K |
|
160
Invesco FTSE RAFI US 1000 ETF
PRF
$9.95B
| – | – |
-6,955
| Closed | -$206K |
|
161
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| – | – |
-9,200
| Closed | -$220K |
|
162
W.P. Carey
WPC
$16.4B
| – | – |
-2,464
| Closed | -$200K |
|
Similar funds
Clearwater Capital Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Clearwater Capital Advisors held 162 positions worth $724M, down 1% from $732M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Clearwater Capital Advisors deployed $34.3M of net new capital in Q3 2022, opening 11 new positions and adding to 64 existing holdings. Its largest new stake was JPMorgan BetaBuilders US Aggregate Bond ETF: 235,697 shares worth $10.7M.
By sector, the portfolio is most concentrated in Technology at 1.7% of assets, up from 1.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares Ultra Short Duration Bond Active ETF, an estimated $24.5M trimmed.
- Clearwater Capital Advisors's largest Q3 2022 buy was JPMorgan BetaBuilders US Aggregate Bond ETF: 235,697 shares worth $10.7M.
- Clearwater Capital Advisors added most to Goldman Sachs ActiveBeta International Equity ETF in Q3 2022, an estimated $17M increase.
- Clearwater Capital Advisors's biggest Q3 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $24.5M.
- Clearwater Capital Advisors fully exited Exelon in Q3 2022, selling an estimated $235K.
- Clearwater Capital Advisors's ten largest holdings make up 46% of its $724M portfolio in Q3 2022.
- Clearwater Capital Advisors opened 11 new positions and closed 7 in Q3 2022.
- Clearwater Capital Advisors's portfolio value fell 1% quarter-over-quarter to $724M.
Based on Clearwater Capital Advisors's 13F filing for Q3 2022, filed 1 Nov 2022.